annual EBIT:
-$291.88M-$330.68M(-852.23%)Summary
- As of today (September 18, 2025), AMLX annual earnings before interest & taxes is -$291.88 million, with the most recent change of -$330.68 million (-852.23%) on December 31, 2024.
- During the last 3 years, AMLX annual EBIT has fallen by -$209.19 million (-252.99%).
- AMLX annual EBIT is now -852.23% below its all-time high of $38.80 million, reached on December 31, 2023.
Performance
AMLX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBIT:
-$42.86M-$5.05M(-13.37%)Summary
- As of today (September 18, 2025), AMLX quarterly earnings before interest & taxes is -$42.86 million, with the most recent change of -$5.05 million (-13.37%) on June 1, 2025.
- Over the past year, AMLX quarterly EBIT has increased by +$10.58 million (+19.80%).
- AMLX quarterly EBIT is now -312.15% below its all-time high of $20.20 million, reached on June 30, 2023.
Performance
AMLX quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$196.97M+$10.58M(+5.10%)Summary
- As of today (September 18, 2025), AMLX TTM earnings before interest & taxes is -$196.97 million, with the most recent change of +$10.58 million (+5.10%) on June 1, 2025.
- Over the past year, AMLX TTM EBIT has dropped by -$42.06 million (-27.15%).
- AMLX TTM EBIT is now -607.64% below its all-time high of $38.80 million, reached on December 31, 2023.
Performance
AMLX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
AMLX EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -852.2% | +19.8% | -27.1% |
| 3 y3 years | -253.0% | +21.0% | -51.1% |
| 5 y5 years | -2246.3% | -398.9% | -2192.8% |
AMLX EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -852.2% | at low | -312.1% | +64.9% | -607.6% | +32.5% |
| 5 y | 5-year | -852.2% | at low | -312.1% | +64.9% | -607.6% | +32.5% |
| alltime | all time | -852.2% | at low | -312.1% | +64.9% | -607.6% | +32.5% |
AMLX EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$42.86M(+13.4%) | -$196.97M(-5.1%) |
| Mar 2025 | - | -$37.80M(-7.0%) | -$207.55M(-28.9%) |
| Dec 2024 | -$291.88M(-852.2%) | -$40.65M(-46.3%) | -$291.88M(+17.1%) |
| Sep 2024 | - | -$75.66M(+41.6%) | -$249.29M(+60.9%) |
| Jun 2024 | - | -$53.44M(-56.2%) | -$154.91M(+90.6%) |
| Mar 2024 | - | -$122.13M(-6414.9%) | -$81.28M(-309.5%) |
| Dec 2023 | $38.80M | $1.93M(-89.7%) | $38.80M(-602.3%) |
| Sep 2023 | - | $18.72M(-7.3%) | -$7.72M(-90.5%) |
| Jun 2023 | - | $20.20M(-1084.0%) | -$81.13M(-47.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | -$2.05M(-95.4%) | -$155.58M(-22.7%) |
| Dec 2022 | -$201.34M(+143.5%) | -$44.59M(-18.4%) | -$201.34M(+8.8%) |
| Sep 2022 | - | -$54.68M(+0.8%) | -$185.06M(+41.9%) |
| Jun 2022 | - | -$54.25M(+13.5%) | -$130.38M(+37.7%) |
| Mar 2022 | - | -$47.81M(+68.9%) | -$94.72M(+58.5%) |
| Dec 2021 | -$82.69M(+106.8%) | -$28.32M(+52.3%) | -$59.77M(+49.3%) |
| Jun 2021 | - | -$18.59M(+44.4%) | -$40.05M(+86.6%) |
| Mar 2021 | - | -$12.87M(+49.8%) | -$21.46M(+149.8%) |
| Dec 2020 | -$39.99M(+221.5%) | -$8.59M | -$8.59M |
| Dec 2019 | -$12.44M | - | - |
FAQ
- What is Amylyx Pharmaceuticals, Inc. annual earnings before interest & taxes?
- What is the all time high annual EBIT for Amylyx Pharmaceuticals, Inc.?
- What is Amylyx Pharmaceuticals, Inc. annual EBIT year-on-year change?
- What is Amylyx Pharmaceuticals, Inc. quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Amylyx Pharmaceuticals, Inc.?
- What is Amylyx Pharmaceuticals, Inc. quarterly EBIT year-on-year change?
- What is Amylyx Pharmaceuticals, Inc. TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Amylyx Pharmaceuticals, Inc.?
- What is Amylyx Pharmaceuticals, Inc. TTM EBIT year-on-year change?
What is Amylyx Pharmaceuticals, Inc. annual earnings before interest & taxes?
The current annual EBIT of AMLX is -$291.88M
What is the all time high annual EBIT for Amylyx Pharmaceuticals, Inc.?
Amylyx Pharmaceuticals, Inc. all-time high annual earnings before interest & taxes is $38.80M
What is Amylyx Pharmaceuticals, Inc. annual EBIT year-on-year change?
Over the past year, AMLX annual earnings before interest & taxes has changed by -$330.68M (-852.23%)
What is Amylyx Pharmaceuticals, Inc. quarterly earnings before interest & taxes?
The current quarterly EBIT of AMLX is -$42.86M
What is the all time high quarterly EBIT for Amylyx Pharmaceuticals, Inc.?
Amylyx Pharmaceuticals, Inc. all-time high quarterly earnings before interest & taxes is $20.20M
What is Amylyx Pharmaceuticals, Inc. quarterly EBIT year-on-year change?
Over the past year, AMLX quarterly earnings before interest & taxes has changed by +$10.58M (+19.80%)
What is Amylyx Pharmaceuticals, Inc. TTM earnings before interest & taxes?
The current TTM EBIT of AMLX is -$196.97M
What is the all time high TTM EBIT for Amylyx Pharmaceuticals, Inc.?
Amylyx Pharmaceuticals, Inc. all-time high TTM earnings before interest & taxes is $38.80M
What is Amylyx Pharmaceuticals, Inc. TTM EBIT year-on-year change?
Over the past year, AMLX TTM earnings before interest & taxes has changed by -$42.06M (-27.15%)